Themis Medicare Limited (THEMISMED) — Announcement | 23 June 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Themis Medicare clarified that recent trading volume spikes are not linked to any pending material disclosures, confirming compliance with SEBI listing rules and regular information dissemination. The clarification addresses investor concerns about unexplained price movements without revealing new financial data.

📄 View Original Announcement (PDF)

About Themis Medicare Limited (THEMISMED)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,142.96 Cr P/E: 28.6 ROE: 9.9% ROCE: 13.6% Div Yield: 0.40%

View full THEMISMED stock details →

📡 Get AI alerts when THEMISMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THEMISMED — Free

📊 More THEMISMED filings

See all THEMISMED filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THEMISMED files new disclosures

Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THEMISMED — Free

Free account · 2 AI queries/day